USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nankai University

USPTO PatentsView assignee record - 47 granted patents across 59 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Nankai ranks #7,050 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 59 technology areas.

#7,050
of 49,997 US assignees by volume
Top 7%
by Innovation Score (55.5/100)
8.4
avg claims per patent
+200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7050 · Foreign Corporation #7,050 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 47 grants
  • UPPER-Q #7,050/49,997
  • PHOTO-FINISH Microchip Technology…
  • CPC-WIDE C07D · 59 areas
  • INNOV-PAR 55.5/100
  • CLAIMS-PAR 8.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +200% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Microchip Technology Germany GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nankai’s 55.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Nankai

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Nankai's Innovation Score is 55.5/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Nankai?

Each dot is one of Nankai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nankai’s own 8.4 claims/patent is at or below the 16.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Nankai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 46.947.047.04747.047.047.1 51015202530 Granted patents (volume) Avg claims / patent Microchip Technology Germany GmbH - 47, 24.4Microchip Technol…Neuboron Medtech Ltd. - 47, 16.15Neuboron MedtechNook Digital, LLC - 47, 17.91Nook DigitalNuovo Pignone SPA - 47, 16.62Nuovo Pignone SPANational Institute of Clean-and-Low-Carbon Energy - 47, 15.51National Institut…Nextiva, Inc. - 47, 18.72NextivaNyxoah SA - 47, 11.74NyxoahOspedale SAN Raffaele S.R.L. - 47, 15.89Ospedale SAN Raff…Nankai University - 47, 8.43Nankai University
Nankai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Nankai's grant cadence moved

Between 2020–2024, Nankai University received 27 grants versus 9 in 2015–2019 (+200% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2023 at 9 grants and bottomed in 2016 at 1. Lead class C07D accounts for 21.3% of the portfolio across 59 subclasses. Volume neighbours: Microchip Technology Germany GmbH (#7,048) and Ospedale SAN Raffaele S.R.L. (#7,056).

Nankai's three-year grant acceleration

Nankai University shows 20 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Nankai's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Nankai holds 47 patents at rank #7,052, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Nankai

By rank, the assignees closest to #7,052 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Nankai's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nankai, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Nankai ranks #819 of 3,165 assignees by patent count in that subclass.

Nankai's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 2015201620182019202020212022202320242025 11
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Nankai University patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 4.3%
2016 1 2.1%
2018 2 4.3%
2019 4 8.5%
2020 2 4.3%
2021 5 10.6%
2022 3 6.4%
2023 9 19.1%
2024 8 17.0%
2025partial year 11 23.4%

Which technologies does Nankai University patent most?

Top 15 of 59 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Nankai University's patent record in context - here's where to go next.

  • Nankai University's lead technology class is C07D (Heterocyclic Compounds), 21.3% of its portfolio - see every assignee active in that class. Explore C07D
  • Ranked #7,050 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Nankai University against Microchip Technology Germany GmbH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 55.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.